Zurawski, B.
90  Ergebnisse:
Personensuche X
?
2

Pembrolizumab with or Without Lenvatinib As First-line Ther..:

Licitra, L. ; Tahara, M. ; Harrington, K....
International Journal of Radiation Oncology*Biology*Physics.  118 (2024)  5 - p. e2-e3 , 2024
 
?
3

41P Efficacy of first-line (1L) nivolumab (N) + ipilimumab ..:

Borghaei, H. ; Balli, D. ; Paz-Ares, L....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S64-S65 , 2023
 
?
 
?
5

64O Lenvatinib plus pembrolizumab, pemetrexed, and a platin..:

Herbst, R.S. ; Cho, B.C. ; Zhou, C....
Immuno-Oncology and Technology.  20 (2023)  - p. 100536 , 2023
 
?
 
?
10

Verbal memory in breast cancer patients treated with chemot..:

Andryszak, P. ; Wiłkość, M. ; Żurawski, B..
European Journal of Cancer Care.  27 (2017)  1 - p. e12749 , 2017
 
?
 
?
12

Callus formation from protoplasts of a maize cell culture:

Chourey, P. S. ; Zurawski, D. B.
Theoretical and Applied Genetics.  59 (1981)  6 - p. 341-344 , 1981
 
?
13

PNO–CI (pair-natural-orbital configuration interaction) and..:

Ahlrichs, R. ; Lischka, H. ; Zurawski, B..
The Journal of Chemical Physics.  63 (1975)  11 - p. 4685-4694 , 1975
 
?
14

pH‐Änderungen während der Oxydation von gefälltem Fe(OH)2 m..:

Krause, A. ; Kołaczkowski, St. ; Zurawski, B.
Zeitschrift für anorganische und allgemeine Chemie.  326 (1963)  3-4 - p. 209-215 , 1963
 
?
15

Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-L..:

Haddad, RI ; Harrington, K ; Tahara, M...
Journal of Clinical Oncology, 2022, pp. JCO2200332 -.  , 2023
 
1-15